Subclinical cardiac dysfunction in obesity patients is linked to autonomic dysfunction: findings from the CARDIOBESE study.
Sanne M SnelderLotte E de Groot-de LaatL Ulas BiterManuel Castro CabezasNadine PouwErwin BirnieBianca M Boxma-de KlerkRené A KlaassenFelix ZijlstraBas M van DalenPublished in: ESC heart failure (2020)
There was a high prevalence (61%) of subclinical cardiac dysfunction in obesity patients without known cardiovascular disease, which appeared to be best identified by GLS. Subclinical cardiac dysfunction in obesity was linked to autonomic dysfunction and male gender, and not to the presence of traditional cardiac risk factors, increased C-reactive protein, increased BNP, increased high-sensitivity troponin I, or increased left ventricular mass.
Keyphrases
- left ventricular
- end stage renal disease
- cardiovascular disease
- metabolic syndrome
- insulin resistance
- ejection fraction
- type diabetes
- weight loss
- newly diagnosed
- chronic kidney disease
- risk factors
- heart failure
- prognostic factors
- heart rate variability
- peritoneal dialysis
- mental health
- heart rate
- adipose tissue
- high fat diet induced
- patient reported outcomes
- skeletal muscle
- aortic stenosis
- hypertrophic cardiomyopathy
- physical activity
- transcatheter aortic valve replacement
- cardiac resynchronization therapy
- catheter ablation
- left atrial